DPP4 inhibitors may increase risk of cholecystitis in T2 Diabetes patients: BMJ - Medical Dialogues
6/28/2022 12:00:00 AM2 years 10 months ago
by Dr.Niharika Harsha B
by Dr.Niharika Harsha B
Increased risk of Cholecystitis was found in Type 2 Diabetes patients who were using Dipeptidyl...
Increased risk of Cholecystitis was found in Type 2 Diabetes patients who were using Dipeptidyl peptidase-4 inhibitors. The study was published in the journal, The BMJ 2022. Diabetes is a pandemic a… [+2899 chars]
full article...